News Study Finds No Link Between Vaccines and Multiple Sclerosis Study Finds No Link Between Vaccines and Multiple Sclerosis by Patricia Inacio, PhD | October 23, 2014 Share this article: Share article via email Copy article link A new study entitled, āVaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseasesā published in theĀ JAMA Neurology journal, reports that no association was observed between vaccinations and an increased risk for Multiple Sclerosis or other central nervous system demyelinating syndromes. Previous studies suggested that vaccination, particularly those for hepatitis B (HepB) and human papillomavirus (HPV), increased the risk for Multiple Sclerosis (MS) and other central nervous system demyelinating syndromes. The suggested link was that these vaccines damaged myelin ā the inner layer of nerve cells ā and a key factor for central nervous system demyelinating syndromes, including MS. However, the topic remains controversial. In the present study, the team of researchers at the Department of Research and Evaluation, Kaiser Permanente and Department of Neurology, Los Angeles Medical Center, aimed to determine the link between vaccination and the risk for MS and other central nervous system demyelinating syndromes. The authors analyzed the health records at the Kaiser Permanente Southern California (KPSC) for KPSC central nervous system demyelinating syndromesĀ registered between 2008 and 2011. They identified 780 patients with central nervous system demyelinating syndromes and 3,885 controls. Vaccination profiles were determined via the electronic vaccination records system. The analysis showed no association between the HepB and HPV vaccinations, as well as other types of vaccinations, and a risk of developing central nervous system demyelinating syndromes for up to three years after vaccination. In younger individuals (below 50 years old), the authors did note an increased risk for central nervous system demyelinating syndromes with any type of vaccination, but the increased risk lasted for only 30 days after the vaccine administration. [adrotate group=”4″] Thus, the authors reported that no long-term association between vaccination and MS or other central nervous system demyelinating syndromes. In particular, to the HPV vaccination, the author acknowledged their findings to be limitative due to the low number of subjects analyzed ā only 92 women were vaccinated against 459 controls. The authors commented on their findings,Ā “Our data do not support a causal link between current vaccines and the risk of MS or other central nervous system demyelinating syndromes. Our findings do not warrant any change inĀ vaccineĀ policy.” Print This Page About the Author Patricia Inacio, PhD Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship. Tags vaccines
April 26, 2024 News by Marisa Wexler, MS Machine learning model predicts CIS to MS conversion risk: Study
April 25, 2024 Columns by Benjamin Hofmeister Finding safety while living with the constant threat of MS progression
April 25, 2024 News by Margarida Maia, PhD Having MS may marginally increase likelihood of cervical cancer: Study